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Abstract: Background: Meta-analysis of observational studies concluded that soft drinks may 
increase the risk of depression, while high consumption of coffee and tea may reduce the risk. 
Objectives were to explore the associations between the consumption of soft drinks, coffee or tea 
and: (1) a history of major depressive disorder (MDD) and (2) the severity of depressive symptoms 
clusters (mood, cognitive and somatic/vegetative symptoms). Methods: Cross-sectional and 
longitudinal analysis based on baseline and 12-month-follow-up data collected from four countries 
participating in the European MooDFOOD prevention trial. In total, 941 overweight adults with 
subsyndromal depressive symptoms aged 18 to 75 years were analyzed. History of MDD, 
depressive symptoms and beverages intake were assessed. Results: Sugar-sweetened soft drinks 
were positively related to MDD history rates whereas soft drinks with non-nutritive sweeteners 
were inversely related for the high vs. low categories of intake. Longitudinal analysis showed no 
significant associations between beverages and mood, cognitive and somatic/vegetative clusters. 
Conclusion: Our findings point toward a relationship between soft drinks and past MDD diagnoses 
depending on how they are sweetened while we found no association with coffee and tea. No 
significant effects were found between any studied beverages and the depressive symptoms 
clusters in a sample of overweight adults. 
Keywords: depression; depressive symptoms clusters; soft drinks; coffee; tea 
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1. Introduction 
Depression is an important public health issue [1,2]. According to the World Health 
Organization [3], depression is a common mental disorder worldwide with more than 300 million 
people affected. The disorder is influenced by social, environmental, psychological, behavioral, 
genetic, hormonal, immunological, biochemical and also neurodegenerative factors [4–6]. Even 
though some of these factors are immutable, variables related to behavioral factors such as lifestyle 
are modifiable. 
Emerging evidence suggests that diet and nutrition have a significant impact on depressive 
symptoms [7,8]. Soft drinks, along with coffee or tea are the most consumed non-alcoholic beverages 
[9]. A frequent consumption of soft drinks and/or carbonated beverages sweetened with sugar or 
with non-nutritive sweeteners (NNSs), has been associated with health problems, with the risk being 
greater when the sweetener is sugar [10–12]. Soft drink consumption either sweetened with sugar or 
with NNSs, was also associated with depressive symptoms and suicidal thoughts in cross-sectional 
studies [13–16] and in a prospective study with a cohort of older USA adults [17]. 
In relation to the underlying mechanisms, a growing body of research shows that added sugars 
or sugar-sweetened beverages and/or food may play an important role in the risk of depression 
[18–20]. Sanchez-Villegas et al. [21] found that added sugars but not sugar-sweetened beverages 
were associated with depression. 
Coffee is one of the most consumed drinks in the world after water [22], comprising 80% of the 
drinks that contain caffeine [23]. Coffee has good nutritional properties. Its lifelong consumption 
produces positive effects on health. For example, inverse correlation was found between its 
consumption and the risk of developing different diseases [22,24,25], and even the risk of mortality 
[26]. Several meta-analyses of observational studies [27–29] indicate that coffee drinking is inversely 
associated with depression symptomatology. The mechanisms of the inverse association of coffee in 
the literature might be mediated by the presence of bioactive constituents, such as caffeine, 
chlorogenic acid, ferulic acid and caffeic acid. These constituents have biological properties that alter 
the parameters associated with the neuroinflammatory hypotheses of depression including 
anti-inflammatory and antioxidant properties [30]. Specially, caffeine mimics the dopamine receptor 
agonists and inhibits both adenosine A1 and A2A receptors. Thus, it reveals a potential 
antidepressant activity [31]. Regarding caffeinated soft drinks such as energy drinks, most studies of 
chronic use provided evidence to suggest that energy drinks are associated with mental health 
problems [32]. 
Tea consumption has also been attributed to having multiple beneficial health properties [33]. 
The meta-analyses of observational studies by Farajzadeh et al. [34] and Dong et al. [35] found a 
significant association between tea consumption and depression symptomatology (35 to 37% lower 
risk of depression among participants who consumed tea), whereas Grosso et al. [28] concluded that 
although tea seems to protect against depression, results are not conclusive and should be taken 
with caution. L-theanine, polyphenols and polyphenol metabolites constituents included in most 
types of tea are able of functioning through multiple pathways simultaneously to reduce the risk of 
depression [36]. 
Previous studies based on the fifth Korean National Health and Nutrition Examination Survey 
(KNHANES) examined the associations between the frequency of consumption of coffee and/or tea 
and self-reported lifetime depression in a general Korean population [37,38]. Both studies concluded 
that frequent consumption of coffee was inversely associated with self-reported lifetime depression 
prevalence. Furthermore, Kim and Kim [37] also found the same association between frequent green 
tea consumption and depression prevalence. The main limitations of these studies were the 
self-reporting of depression (participants had not been diagnosed by a mental health professional), 
and the authors did not include an adjustment for overall diet score in the analysis. 
In the most recent meta-analysis of observational studies carried out to date [27], the authors 
concluded that soft drinks may increase the risk of depression, while high consumption of coffee 
and tea may reduce the risk of depression. A better understanding of the relationship between the 
non-alcoholic beverages and mental health would be necessary. Depression it is often a condition 
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with relapses and recurrences [39]. Providing knowledge about the relationship between previous 
depressive episodes and beverages consumption could help to prevent future depressive episodes 
by promoting healthy drinking patterns. In addition, depressive symptom patterns/clusters have not 
yet been studied. Previous works proposed to differentiate three symptom clusters [40,41]: mood 
symptoms (e.g., feeling sad, anxious, reduced pleasure or interest), cognitive symptoms (e.g., 
concentration difficulties, pessimism, suicidal thoughts), and somatic/vegetative symptoms (e.g., 
sleeping problems, appetite increase/decrease, aches and pains). 
In the MooDFOOD [42,43] prevention trial, a multicenter 2 × 2 factorial randomized clinical trial 
to study the effect of multinutrient supplementation and food-related behavioral activation therapy 
(FBC) on the prevention of major depressive disorder (MDD) among 1025 overweight adults with 
subsyndromal depressive symptoms was conducted; results showed that multinutrient 
supplementation compared with placebo and food-related behavioral activation therapy compared 
with no-therapy did not reduce episodes of MDD at a 12-month follow-up. In the context of this 
large-scale prevention trial, the aims of the present work were to examine by exploratory post-hoc 
analysis: (1) the relationship between certain non-alcoholic beverages (soft drinks, coffee and tea) 
and past MDD diagnosis; and (2) to explore the potential differences in depressive symptom clusters 
(mood symptoms, cognitive symptoms, and somatic/vegetative symptoms) in relation to these 
non-alcoholic beverages consumption. 
2. Materials and Methods 
2.1. Design 
Baseline and 12-month-follow-up data were collected from four countries participating in the 
MooDFOOD prevention trial. MooDFOOD is a multi-country collaborative European project on the 
role of diet, food-related behavior, and obesity in the prevention of depression, registered as a 
clinical trial (www.clinicaltrials.gov; number of identification: NCT02529423). The main objective of 
MooDFOOD was to examine the feasibility and effectiveness of two different nutritional strategies 
to prevent a new episode of MDD in high-risk overweight people with subsyndromal symptoms of 
depression. The trial design was a 2 × 2 factorial randomized clinical trial. Participants were 
allocated one of four intervention groups: (1) daily multi-nutrient supplements (1412-mg omega-3 
fatty acids, 30-μg selenium, 400-μg folic acid, and 20-μg vitamin D3 plus 100-mg calcium); (2) 
placebo; (3) daily multi-nutrient supplements plus food-related behavioral activation therapy 
(specific nutritional advice on improving food-related behaviors and to follow a Mediterranean style 
diet); (4) placebo plus food-related behavioral activation therapy. 
A detailed description of the MooDFOOD study design and protocol can be found in Roca et al. 
[43]. 
2.2. Study Population 
A total of 1025 participants from four different European countries (The Netherlands, United 
Kingdom, Germany and Spain) were recruited between September 2015 and October 2016. The 
recruitment consisted of MooDFOOD brochures and posters in public areas, websites, local 
advertisements on social media, and articles in local newspapers, mailings to registered subjects in 
the general practice settings or in other registers (e.g., city registers), invitation letters, press releases 
to the national press as well as recruitment via other studies and trials conducted at the four sites. 
Inclusion criteria were: aged between 18 and 75 years old; meeting criteria for being overweight 
or obese according to a body mass index (BMI) between 25 and 40 kg/m2; and report subsyndromal 
symptoms of depression measured by the Patient Health Questionnaire (PHQ-9) score of at least 5 
points [44]. Exclusion criteria were: current episode of MDD according to the psychiatric Diagnostic 
and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) [45] criteria (including the past 
6 months) assessed by a structured MINI International Neuropsychiatric Interview 5.0 (MINI 5.0; 
[46]; current eating disorder; history of psychosis, bipolar disorder, substance dependence or other 
severe psychiatric disorder that requires specialized clinical attention; history of bariatric surgery; 
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currently pregnant or breastfeeding; current severe life-threatening physical disease (assessed using 
self-report); severe cognitive impairment limiting the participation in the study assessed by the 
ability to complete the screening instruments in an adequate manner; currently receiving a 
behavioral intervention that interferes with MooDFOOD prevention trial intervention; and finally, 
unwilling to stop using specific dietary supplements that are used or are competing with 
MooDFOOD prevention trial. 
All subjects gave their informed consent for inclusion before they participated in the study. The 
study was conducted in accordance with the Declaration of Helsinki and it was approved by the 
Ethics Committee of the Govern de les Illes Balears, Palma, Spain (10 March 2015, number IB 2515/15 
PI); the Ethics Committee of the University Leipzig, Medical Faculty, Germany (30 June 2015, 
number 167/15-ff); the Ethics Committee of the VU Medical Center Amsterdam, the Netherlands (8 
July 2015, number 2015.160); and the NHS National Research Ethics Service (NRES) Committee for 
University of Exeter, SouthWest, UK (3 August 2015, number 15/SW/0153). Eligible participants 
underwent a face-to-face baseline interview by a trained research assessor. Baseline interviews 
included the assessment of a lifetime history of depression through MINI 5.0 depression section [46], 
sociodemographic status, physical measurement (height, weight, waist circumference, blood 
pressure, blood sampling) and self-administered questionnaires. They were followed up for 12 
months. Participants were allocated to one of four intervention groups: (1) daily multi-nutrient (2) 
placebo; (3) daily multi-nutrient supplements plus food-related behavioral activation therapy; (4) 
placebo plus food-related behavioral activation therapy. 
2.3. Participants 
A total of 941 participants who fulfilled the Food Frequency Questionnaire at baseline and at a 
12-month follow-up were included in the present work. Participants with no or incomplete data on 
the on the food intake self-report questionnaire were excluded (n = 84). 
2.4. Measures 
2.4.1. Presence of Lifetime MDD 
MINI International Neuropsychiatric Interview 5.0 (MINI 5.0; [46]). A brief standardized 
diagnostic interview used to assess disorders described in the Diagnostic and Statistical Manual of 
Mental Disorders, Fourth Edition (DSM-IV; [45]). The Depression section of the interview was 
specifically used to assess lifetime history of MDD. 
2.4.2. Depression Measurements 
Inventory of Depressive Symptomatology-Self Report [47]. A 30-item self-administered 
questionnaire ranging from 0 to 84 was used to assess the severity of depressive symptoms in the 
last week. Items are rated on a scale from 0 (no symptom present) to 3 (severe impairment). A cut-off 
point of 18 or above indicate the presence of clinically relevant depressive symptomatology. The 
scale presents acceptable psychometric properties [48,49]. In accordance with previous studies 
[39,40], individual symptoms were categorized into symptoms clusters: mood cluster (16 item 
ranged from 0 to 30); cognitive cluster (4 items ranged from 0 to 12); and somatic/vegetative cluster 
(ranged from 0 to 48). See Supplementary Table S1. 
2.4.3. Non-Alcoholic Beverages Consumption 
Food Frequency Questionnaire (GA2LEN-FFQ; [50]). This is a self-report questionnaire to 
assess dietary intake in the last 12 months. It includes a wide range of foods and nutrients (a list of 
200 foods and drinks) representative of European diet. Foods are classified into groups by using the 
European Food Group (EFG) classification system [51]. The Beverages section was used in the 
present study, specifically non-alcoholic beverages (carbonated/soft drinks with sugar or with NNSs 
measured in units of 200 mL) and tea/coffee groups measured in units of a cup. Whether sugar was 
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added to tea or coffee was not recorded. The frequency of consumption is assessed in eight 
categories: never/rarely, 1–3 times a month, once a week, 2–4 times a week, 5–6 times a week, once a 
day, 2–3 times a day, 4 or more times a day. 
2.4.4. Lifestyle and Health Status 
Adherence to the MooDFOOD diet was assessed in a range from 0 to 77 based on the 
GA2LEN-FFQ [50]. Higher scores indicated a better adherence to the MooDFOOD diet based on the 
intake of 11 components: vegetables, fruit, fish, legumes or pulses, meat, whole grain products, 
low-fait dairy, olive oil, soft drinks, processed food and alcohol. Physical activity was assessed by 
the last item included in the Short Questionnaire to Assess Health-Enhancing Physical Activity 
(SQUASH; [52]), which refers to “average of days per week that the subject does physical exercise for 
at least 30 min”. Anthropometric measurements such us height and weight were taken to calculate 
the BMI (weight kilograms divided by height in square meters (Kg/m2). Blood pressure was also 
measured. Basal interviews included questions about the presence of somatic/chronic diseases 
(diabetes and stomach or intestinal ulcer were selected for the preset study), currently smoking, and 
alcohol consumption. Alcohol consumption was explored by using AUDIT test [53]. It consisted in a 
10-item range from 0 to 4 to assess the risk alcohol consumption, dependence symptoms and 
harmful alcohol consumption. The sum of items ranging from 0 to 40 indicates the level of risk and 
dependence of alcohol consumption. 
2.4.5. Sociodemographic Variables 
Country, age, sex, marital status and educational level were collected. 
2.5. Outcomes and Data Analysis 
Descriptive data were computed in terms of means, standard deviations, or percentages for the 
overall sample and per European Country. Differences between countries in sociodemographic, 
clinical, lifestyle and health as well as beverage consumption variables were examined. Beverages 
consumption was categorized as a dummy variable, and we defined it in three levels of frequency 
use. Soft drinks: <1 unit a week; 1 to 6 units a week; 1 or more units a day. Coffee and tea: <1 cup a 
day; 1 to 3 cups a day; >3 cups a day. 
Binary logistic regression analysis was conducted with history of MDD as dependent variable 
and categorized as a dichotomous variable (history of MDD vs. no history of MDD). Odds ratios 
(ORs), 95% confidence intervals (CIs) and corresponding p values of lifetime depression presence 
associated with beverages consumption were calculated. Normality distribution of data was tested 
with Shapiro–Wilk test. Generalized linear models using a logistic regression formula were 
performed with all variables to explore the association between the frequency of beverages 
consumption as determinants entered jointly, and specific depressive symptom clusters (mood, 
cognitive and somatic) as outcomes measured by the IDS30-SR at 12-month follow-up. In addition, 
depression severity overall score was also explored as an outcome. R2, β coefficients, F value, 95% 
confidence intervals (CIs), and significance level (p) are reported. Baseline IDS30-SR score was 
included as covariate to interpret the regression coefficients as change compared with baseline. A 
stepwise backward formula-based model by AIC was performed to select final model. All analyses 
were adjusted for site, gender, sex, marital status, educational level (plus intervention group in 
longitudinal analysis), and in Model 1, and then, in Model 2, we added all identified potential 
confounders (BMI, MoodFood diet score, smoking, alcohol use, physical activity, high blood 
pressure, diabetes, and stomach or intestinal ulcer). We followed two strategies to evaluate the effect 
of the country variable. First, the country variable was introduced as a random effect, assuming that 
the observed variability could be conditioned by this variable, and second, the data were stratified 
by each country. Tests of assumptions of collinearity of the independent variables showed that 
multicollinearity was not a concern. 
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Categorical variables were coded as dummy or dichotomous variables: site (Germany, United 
Kingdom, Spain, The Netherlands); sex (male vs. female); educational level (lower: no studies or 
primary; middle: secondary studies; higher: university studies); intervention group (placebo; 
multi-nutrient supplements; placebo plus therapy; multi-nutrient supplements plus therapy), 
smoking (no vs. yes); high blood pressure (no vs. yes); diabetes (no vs. yes); stomach or intestinal 
ulcer (no vs. yes). 
All statistical analyses were performed by IBM SPSS v24 (SPSS Inc., Chicago, IL, USA) and R 
version 3.6. The significance level was at a two-tailed probability <0.05. 
3. Results 
3.1. Descriptives 
Table 1 describes the baseline data. Of the 941 participants, 275 were from Germany; 227 from 
United Kingdom; 215 from Spain; and 224 from The Netherlands. Mean age was 46.77 (SD = 12.94), 
ranging from 18 to 75; 75.3% were female; 48.1% of the sample had middle level of education, 42.2% 
higher education whereas the remaining 9.7% had a lower level. Lifetime prevalence of MDD was 
33.2% (n = 312), with rates being significantly higher in the Netherlands and the United Kingdom 
sample in comparison with the other countries (p < 0.001). Higher alcohol use scores measured by 
AUDIT indicated a higher prevalence of MDD history diagnosis (p = 0.011). The severity of average 
depressive symptomatology was 21.74 (SD = 10.02) in the IDS30-SR, indicating mild depressive 
symptoms in the general sample. BMI average was 31.32 (SD = 3.95). A minority of the sample 
currently smoked (17.5%) and the mean of the score obtained in AUDIT test about alcohol use was 
3.88 (SD = 3.67), indicating a normal consumption on average. On average, subjects did physical 
activity 3.61 (SD = 2.34) days/week. With regards to medical comorbidities, 30.8% of the sample 
suffered from high blood pressure, 5.2% from diabetes and 3.9% from stomach ulcer. Most of the 
sample (77.7%) drank less than 1 glass per week of carbonated/soft drinks with sugar, similar to the 
consumption of carbonated/soft drinks with NNSs (64%). In our sample, coffee is the most frequent 
drink; 56.7% of participants consumed 1 to 3 cups per day, whereas 66.6% of sample consume less 
than 1 cup of tea a day.  
The sample was heterogeneous between countries; chi-squared tests showed country 
differences in all the variables except for sex, diabetes and stomach or intestinal ulcer (see 
Supplementary Table S2). 
Table 1. Baseline characteristics of the 941 included participants. 
 
Overall  History of Depression  
(n = 941) Range 
Yes 
(n = 312) 
No 
(n = 629) 
p 
Value 
Demographics      
   Age, Mean, (SD) 46.8 (12.9) 18–75 46.5 (12.7) 46.9 (13.0) 0.634 
   Sex      0.800 
Female, n (%) 709 (75.3%)  233 (74.7%) 476 (75.7%)  
Male, n (%) 232 (24.7%)  79 (25.3%) 153 (24.3%)  
   Marital status: couple, n (% yes) 566 (60.1%)  199 (63.8%) 367 (58.3%) 0.125 
   Site:      <0.001 
Germany, n (%) 275 (29.2%)  61 (19.6%) 214 (34.0%)  
United Kingdom, n (%) 227 (24.1%)  123 (34.9%) 104 (16.5%)  
Spain, n (%) 215 (22.8%)  56 (17.9%) 159 (25.3%)  
The Netherlands, n (%) 224 (23.8%)  72 (23.1%) 152 (24.2%)  
Level of education     0.115 
   Lower education, n (%) 91 (9.7%)   22 (7.05%) 69 (11.0%)  
   Middle education, n (%) 453 (48.1%)  149 (47.8%) 304 (48.3%)  
   Higher education n (%) 397 (42.2%)  141 (45.2%) 256 (40.7%)  
Lifestyle      
   BMI, Mean (SD) 31.3 (3.95) 24–45 31.1 (3.74) 31.4 (4.05) 0.252 
   MoodFOOD diet score, Mean (SD) 51.7 (7.03) 24–71 51.9 (7.13) 51.5 (6.98%) 0.417 
   Smoking, n (% yes)  165 (17.5%)  56 (17.9%) 109 (17.3%) 0.885 
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   Alcohol use, Mean (SD) 3.88 (3.67) 0–25 4.3 (3.94) 3.66 (3.51%) 0.011 
   Physical activity, Mean (SD) 3.61 (2.34) 0–7 3.73 (2.33) 3.55 (2.35) 0.259 
Medical comorbidities      
   High Blood pressure, n (% yes) 290 (30.8%)  83 (26.6%) 207 (32.9%) 0.058 
   Diabetes, n (% yes) 49 (5.2%)  14 (4.5%) 35 (5.6%) 0.586 
   Stomach or intestinal ulcer, n (% yes) 37 (3.9%)  8 (2.6%) 29 (4.6%) 0.179 
Psychiatric characteristics      
   Depressive Symptoms IDS30-SR, 
Mean (SD)  
21.74 (10.02) 0–55 23.7 (10.1) 20.8 (9.83) <0.001 
   Mood symptom cluster, Mean (SD) 7.49 (4.85) 0–26 8.46 (5.04) 7.00 (4.68) <0.001 
   Cognitive symptom cluster, Mean 
(SD) 
2.77 (1.99) 0–9 3.18 (2.01) 2.57 (1.94) <0.001 
   Somatic symptom cluster, Mean (SD) 11.48 (4.88) 0–28 12.0 (4.74) 11.2 (4.93) <0.001 
Beverages consumption      
   Soft drinks with sugar      0.317 
<1/week, n (% yes) 731 (77.7%)  235 (75.3%) 496 (78.9%)  
1–6/week, n (% yes) 165 (17.5%)  58 (18.6%) 107 (17.0%)  
≥1/day, n (% yes) 45 (4.8%)  19 (6.1%) 26 (4.1%)  
   Soft drinks with artificial sweetener                  0.109 
<1/week, n (% yes) 602 (64.0%)  199 (63.8%) 403 (64.2%)  
1–6/week, n (% yes) 232 (24.7%)  86 (27.6%) 146 (23.2%)  
≥1/day, n (% yes) 106 (11.3%)  27 (8.6%) 79 (12.6%)  
   Coffee      0.956 
<1/day, n (% yes) 290 (30.8%)  98 (34.4%) 192 (30.5%)  
1–3/day, n (% yes) 534 (56.7%)  175 (56.1%) 359 (57.1%)  
>3/day, n (% yes) 117 (12.4%)  39 (12.5%) 78 (12.4%)  
   Tea      
<1/day, n (% yes) 627 (66.6%)  193 (61.9%) 434 (69.0%) 0.071 
1–3/day, n (% yes) 244 (25.9%)  90 (28.8%) 154 (24.5%)  
> 3/day, n (% yes) 70 (7.44%)  29 (9.29%) 41 (6.52%)  
3.2. Beverages Consumption and History of Depression 
Table 2 presents the results of the consumption rates and its association with the presence of a 
past MDD diagnosis. Consumption of ≥1 unit a day of soft drinks with sugar was related to a higher 
prevalence of MDD history diagnosis (Odds Ratio (OR) = 2.28, 95% confidence interval (CI) = 
1.17–4.36; R2Tjur = 0.092) compared with <1 unit a week frequency consumption. The opposite 
association was found in the consumption of soft drinks with NNSs: ≥1 unit a day frequency of 
consumption was related to lower rates of MDD history diagnoses (OR = 0.55, 95% CI = 0.33–0.89; 
R2Tjur = 0.092). These results are obtained after adjusting for site, age, sex, marital status, level of 
education (model 1). These results were also obtained in model 2 with the additional adjustment for 
BMI, MooDFOOD diet score, smoking, alcohol use, physical activity, high blood pressure, diabetes, 
and stomach or intestinal ulcer: OR for MDD history diagnosis among subjects who consumed ≥1 
unit a day of soft drinks with sugar was 2.41 (95% CI = 1.20–4.77; R2Tjur = 0.096) and OR = 0.55 (95% CI 
= 0.32–0.90; R2Tjur = 0.096) for those who consumed ≥1 unit a day of soft drinks with NNSs. No 
associations were observed between frequent consumption of coffee and tea and a history of MDD 
diagnosis. 
Table 2. Cross-sectional associations between basal beverage consumption frequency and history of 
major depression diagnosis. 
Consumption Frequency Model 1 a  Model 2 b  
 OR (95% CI) p Value OR (95% CI) p Value 
Carbonated/soft drinks 
with sugar (200 mL) 
    
<1/week 1.00 (reference) - 1.00 (reference) - 
1–6/week 1.22 (0.80–1.84) 0.347 1.27 (0.82–1.94) 0.281 
≥1/day 2.28 (1.17–4.36) 0.013 2.41 (1.20–4.77) 0.012 
Carbonated/soft drinks 
NNSs (200 mL) 
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<1/week 1.00 (reference) - 1.00 (reference)  
1–6/week 1.10 (0.77–1.56) 0.612 1.10 (0.77–1.58) 0.594 
≥1/day 0.55 (0.33–0.89) 0.019 0.55 (0.32–0.90) 0.020 
Coffee (1 cup)     
<1/day 1.00 (reference) - 1.00 (reference) - 
1–3/day 1.23 (0.88–1.72) 0.228 1.14 (0.81–1.61) 0.454 
>3/day 1.08 (0.66–1.77) 0.750 1.00 (0.60–1.65) 0.994 
Tea (1 cup)     
<1/day 1.00 (reference) - 1.00 (reference) - 
1–3/day 1.17 (0.83–1.64) 0.374 1.18 (0.84–1.67) 0.341 
>3/day 1.07 (0.61–1.85) 0.810 1.10 (0.63–1.92) 0.732 
Abbreviations: OR, odds ratio; CI, confidence interval; NNSs, non-nutritive sweeteners; (a) adjusted 
for site, age, gender, marital status, level of education; (b) adjusted for site, age, gender, marital 
status, level of education, BMI, MooDFOOD diet score, smoking, alcohol use, physical activity, high 
blood pressure, diabetes, and stomach or intestinal ulcer. 
When we stratified these analyses per country, the associations between the different 
non-alcoholic beverages and MDD history diagnosis were only significant in Spain and The 
Netherlands. In the Spanish sample, consumption of ≥1 unit a day soft drinks with NNSs was 
associated with lower rates of MDD history diagnoses (OR = 0.20, 95% CI = 0.03–0.78; p = 0.042) in 
comparison with <1 unit a week frequency consumption. In The Netherlands sample, consumption 
of 1 to 3 cups of coffee a day, was related to higher rates of MDD history diagnoses (OR = 2.73, 95% 
CI 1.17–6.78; p = 0.024) compared with <1 cup a day consumption. 
3.3. Beverages Consumption and Depression Severity per Symptoms Clusters 
Generalized linear models showed no significant associations of the consumption of any 
studied beverages and overall depression severity score at 12-month follow-up. Mood, cognitive and 
somatic clusters entered separately to the analysis showed no significant effects associations with 
basal consumption rates in any of the non-alcoholic beverages studied (see Table 3). All analyses 
were adjusted for IDS30-SR baseline scores, site, age, gender, marital status, level of education, 
intervention group, with the additional adjustment of BMI, smoking, alcohol use, physical activity, 
high blood pressure, diabetes, and stomach or intestinal ulcer. Country variable was introduced as a 
random effect in the models. Results derived from generalized linear model analysis are shown in 
Table 3. 
Table 3. Generalized linear models on the associations between basal beverage frequency 
consumption and 12-month follow-up depression severity (total score, mood, cognitive and somatic 
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* Adjusted for site, age, gender, marital status, level of education, BMI, MooDFOOD diet score, 
smoking, alcohol use, physical activity, high blood pressure, diabetes, and stomach or intestinal 
ulcer, intervention group and IDS30-SR basal score. CI, confidence interval. 
4. Discussion 
The post-hoc analysis based on baseline data from the large-scale MooDFOOD prevention trial 
with the aim of exploring the relationship between certain non-alcoholic beverages (soft drinks 
sweetened with sugar or with NNSs, coffee and tea) and past MDD diagnosis showed that 
consuming at least one drink a day of soft drinks sweetened with sugar was associated with a higher 
prevalence of MDD history diagnosis than consuming less than one drink a day. In contrast, 
consuming at least one drink a day of soft drinks sweetened with NNSs was inversely associated 
with previous MDD diagnosis rates in comparison with lower consumption frequencies. 
This is the first study to analyze the associations between a history of MDD diagnosis and the 
consumption of soft drinks, coffee and tea in overweight subjects with subsyndromal depressive 
symptoms. We found no association of coffee or tea consumption and previous MDD. Contrary to 
our findings, previous studies based on the fifth Korean National Health and Nutrition Examination 
Survey concluded that frequent consumption of coffee [37,38] and green tea ([37] was inversely 
associated with self-reported lifetime depression prevalence. 
Regarding the second post-hoc analysis with the aim of exploring the potential differences in 
the severity of depressive symptom clusters at 12-month follow-up (mood symptoms, cognitive 
symptoms, and somatic/vegetative symptoms) in relation to the consumption of these non-alcoholic 
beverages at baseline, it showed no significant effects of the consumption of any studied beverage 
and depression severity neither on the global scale nor in mood, cognitive or somatic clusters. 
This is the first study that has examined the association between non-alcoholic beverages intake 
and different specific depressive symptoms. 
Results obtained about soft drinks consumption and their relationships with depression 
severity are partially consistent with those obtained in the literature. For example, [17] showed that a 
consumption of ≥4 cans/day of soft drinks, compared with non-drinkers, was associated (OR = 1.30; 
95%CI: 1.17–1.44) with a higher prevalence of depression among older adults, both sweetened with 
sugar or with NNSs soft drinks. The observed inverse association between drinks consumption was 
supported by [27] where the pooled Risk Ratio (RR) for the high vs. low category consumption was 
1.36 (95% CI 1.24–1.50). 
Consistent with our results about coffee intake, a longitudinal study in an Italian population 
[54] found no significant association between coffee consumption and depressive severity. Contrary 
to these results, meta-analyses of observational studies [27–29] concluded that coffee consumption is 
significantly associated with a decreased risk of depression. As observed in the most recent 
meta-analysis [27] based on five cross-sectional and three prospective cohorts of observational 
studies, pooled RRs of depression diagnosis for the high vs. low categories of consumption were 0.73 
(95% CI 0.59–0.90). For dose–response analysis, [28] report a nonlinear J-shaped relation establishing 
the peak of protective effect on depressive symptoms for 400 mL/day. In fact, a prospective study 
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carried out in a Finish population [55] with a sample of more than 40,000 subjects, found that 
amongst the people who consumed more than 8 cups/day of coffee, the risk of suicide was 58% 
higher compared with moderate consumers (1–7 cups/day). 
In the case of tea consumption, our results were consistent with findings obtained in the [28] 
meta-analysis and also in previous longitudinal [54] prospective [17] and cross-sectional [56] studies. 
In contrast, other meta-analyses of observational studies [27,28,34,35] concluded that frequent tea 
consumption was associated with a decreased risk of depression (e.g., RR = 0.71; 95% CI = 0.55–0.91; 
[27]. Regarding dose-response analysis, Dong et al. [35], found a linear association between tea 
consumption and the risk of depression, and, specifically an increment of three cups/day of tea 
consumption was associated with a decrease in the risk of depression of 37% (RR = 0.63; 95% CI = 
0.55–0.71). 
One potential explanation for the contrasting results is that we adjusted for diet quality by 
adding an overall diet score as a confounder to our model. Kawada et al. [57] reported the need to 
specify the effect of food intake over the lack of consistent results among studies. Another 
explanation is the low percentage of consumption of certain beverages in comparison with other 
studies. Specifically, more than the 70% of the sample consumed less than one soft drink sweetened 
with sugar a week, more than 60% less than one soft drink sweetened with NNSs and 64% 
consumed less than one cup of tea a day. These low percentages make it difficult to interpret the 
results. Higher consumption of NNSs in overweight and obese people has been reported by other 
authors (e.g., [58]). These authors found a positive significant association between NNSs 
consumption per day and BMI status. However, despite reducing sugar consumption, it was not 
associated with a lower caloric intake, which suggests a compensatory increase in energy intake 
from other food sources. Beverage consumption behavior in this population may be different 
compared to the general population, so we must be cautious with the findings of our study. 
Mechanisms underlying about the effect of fructose or sucrose from soft drinks and how it could be 
affecting depression remains unknown. Future biological research is needed to explain 
neurobiological or molecular concepts of our findings. 
The present study has some limitations; first, the post-hoc design limits its applicability and 
generalizability and its cross-sectional design in the analysis of MDD history diagnosis limits the 
extraction of causal relationships of soft drinks, coffee and tea consumption with the risk of 
depression. Second, the low percentage of participants that consumed soft drinks frequently. Power 
calculations to determine the appropriate sample size would be useful to provide more confidence 
in the generalizability of these results. The third limitation is the non-differentiation of the 
sweetening method: what percentage or type of sugar and NNSs were included in the soft drinks; if 
coffee or tea were sweetened with sugar, sweetened with NNSs or non-sweetened. Several studies 
have linked sugar consumption with a risk of depression [18,19]. We have obtained different results 
in soft drinks dependent on if they are sweetened with sugar or with NNSs, and this may also 
possibly be similar in coffee and tea. Furthermore, it would be desirable to study the differences 
between caffeinated or non-decaffeinated coffee since caffeine properties are attributed with 
preventing depression along with other components of coffee. Finally, due to the specific 
characteristics of the sample, it is not a representative sample of the general population. 
Our study has some strengths such as its multi-country sample. This is the first study that has 
analyzed associations between a history of MDD diagnosis and consumption of soft drinks, coffee 
and tea in subjects with subsyndromal depressive symptoms, focusing on several of the most 
consumed beverages, and analyzing soft drinks sweetened in different ways (sugar vs. NNSs). In 
addition, it is the first longitudinal study that has examined the association between beverage intake 
and differentiated specific depressive symptom clusters (mood, cognitive and somatic/vegetative 
symptoms). Finally, the inclusion of an overall nutritional index (MooDFOOD diet score) as a 
confounder was a strength. 
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These findings could add significant information in the growing body of literature on the role of 
healthy eating in the prevention of depression, helping health care providers to develop healthy 
eating recommendations and guidelines. It also provides greater emphasis for the importance of diet 
as a common modifiable risk factor in the prevention of depression in vulnerable population. 
5. Conclusions 
Soft drinks sweetened with sugar consumption at baseline were positively associated with 
MDD history diagnosis prevalence in a multi-country sample of overweight participants with 
subsyndromal depressive symptoms whereas soft drinks sweetened with NNSs were inversely 
associated for the high vs. low categories of intake. No relationships were found about coffee and tea 
consumption. Longitudinal analysis of mood, cognitive and somatic/vegetative clusters showed no 
significant effects associated with basal consumption rates in any of the non-alcoholic beverages 
studied. Further evidence is needed to address the effect the beverages on the MDD onset. 
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